ArticleJournal of thoracic disease2018

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway.

Ramon Andrade De Mello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.